Connection
Susana Arrigain to Thiazolidinediones
This is a "connection" page, showing publications Susana Arrigain has written about Thiazolidinediones.
|
|
Connection Strength |
|
|
|
|
|
0.019 |
|
|
|
-
Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol. 2009 Jun; 46(2):145-54.
Score: 0.019